CTOs on the Move

Sonoma Biotherapeutics

www.sonomabio.com

 
Sonoma Biotherapeutics is inventing the future of living therapies for autoimmune disease — safe, effective treatments as unique as each individual patient. Regulatory T cell therapies that harness a patient`s own immune cells, powerful next generation gene editing techniques and advanced manufacturing and quality assurance processes. Sonoma`s mission is to create a best-in-class regulatory T cell therapy that delivers long-lasting, highly efficacious treatments leading to cures across a spectrum of autoimmune and degenerative diseases.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.sonomabio.com
  • 201 Haskins Way Suite 203
    South San Francisco, CA USA 94080
  • Phone: 415.992.6245

Executives

Name Title Contact Details
Heidi Hagen
Chief Technical Officer Profile

Funding

Sonoma Biotherapeutics raised $40M on 02/06/2020
Sonoma Biotherapeutics raised $30M on 09/30/2020

Similar Companies

CuraSen Therapeutics

CuraSen Therapeutics is focused on the discovery and development of therapies to treat neurodegenerative diseases, including Parkinson`s Disease, Alzheimer`s Disease and less common neurodegenerative disorders.

Scientia Advisors

Scientia Advisors is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CARBONDALE CLINIC AND SURGERY

CARBONDALE CLINIC AND SURGERY is a Carbondale, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Targacept

Targacept`s clinical pipeline is built on a unique class of therapeutic targets.

One Tast

One Tast is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.